BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
STEX
Streamex Corp.
There isn't enough reported data to score STEX yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
STEX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| N/A | |
| N/A |
STEX's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like STEX.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
STEX PE Valuation
STEX has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 6.3x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
STEX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect STEX to return to profit, with revenue growing.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus STEX down 223%.
STEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.05 | — |
| Q3 2022 | -$7.13 | +$3.07 |
| Q2 2022 | -$7.90 | +$4.00 |
| Q1 2022 | -$8.99 | +$7.71 |
| Q4 2021 | -$9.58 | +$9.12 |
| Q3 2021 | -$10.20 | +$12.30 |
| Q2 2021 | -$11.90 | +$9.30 |
| Q1 2021 | -$16.70 | +$1.10 |
| Q4 2020 | -$18.70 | -$2.20 |
STEX is still losing money, but far less than before: $8.74 per share over the past year, against $22.50 at its worst in late 2020.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
STEX has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus up 1,015% for STEX.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over STEX on profitability, with a higher operating margin.
STEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $13K | +8.3% |
| Q1 2024 | $14K | +180% |
| Q4 2023 | $12K | -91% |
| Q3 2023 | $1K | -99% |
| Q1 2023 | $5K | -38% |
| Q4 2022 | $135K | +1588% |
| Q3 2022 | $135K | +25% |
| Q2 2022 | $8K | -96% |
STEX's revenue is recovering but still below its 2021 peak: $145,000 last quarter, up 1015% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12397% | N/A |
| Q2 2026 | -10384% | N/A |
| Q4 2024 | -9100% | +42292 points |
| Q2 2024 | -40708% | N/A |
| Q1 2024 | -24550% | +123170 points |
| Q4 2023 | -51392% | -46208 points |
| Q3 2023 | -405100% | -400296 points |
| Q1 2023 | -147720% | -46908 points |
STEX's operating margin was −12397% last quarter, up 12153 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over STEX on cash generation, producing positive trailing cash flow while its opponent burns cash.
STEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.1M | -$1.1M |
| Q2 2026 | -$11.7M | -$10.5M |
| Q1 2026 | -$10.2M | -$9.1M |
| Q4 2023 | -$2.9M | +$1.2M |
| Q3 2023 | -$3.9M | +$1.1M |
| Q2 2023 | -$5M | +$1.7M |
| Q1 2023 | -$5.7M | +$303K |
| Q4 2022 | -$4.2M | +$1.7M |
STEX's free cash flow was −$31M over the past year, against −$10M the year before. Free cash flow isn't a meaningful measure for financial services companies like STEX.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over STEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
STEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +3.3M shares |
| 1 year | +569% | +158M shares |
| 3 years | +2672% | +179M shares |
| 5 years | +6542% | +183M shares |
STEX has 185M diluted shares, up 569% from a year ago.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
STEX Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
STEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 2.9 | Oversold |
STEX's weekly RSI is 34 (neutral) and its Stochastic is 3 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
STEX PE vs Financial Services Sector
STEX has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has stronger trend alignment. BAC is above 1 of 5 weekly averages versus STEX above 0 of 3.
STEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.46 | 33% below |
| 20 week MA | $0.66 | 53% below |
| 50 week MA | $1.52 | 80% below |
STEX is in a downtrend: it's below all three of its weekly moving averages, and 80% below its 50-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over STEX on returns for 2026, with the stronger performance.
STEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $6.27 | $3.14 | -50% |
| 2026 YTD | $3.14 | $0.31 | -90% |
STEX has finished every year since 2025 lower, and it's down 90% so far in 2026.